Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese Törngren, Anders Kvist, Markus Ringnér, Inge Marie Svane, Göran Jönsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf6ac8b989324b07a79b03ff14d6349c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Martin Lauss, et al.
Publicado: (2017) -
Neoantigens elicit T cell responses in breast cancer
por: Takafumi Morisaki, et al.
Publicado: (2021) -
Protein citrullination as a source of cancer neoantigens
por: Makoto Kobayashi, et al.
Publicado: (2021) -
Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
por: Bo Wen, et al.
Publicado: (2020) -
Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
por: Melanie Boxberg, et al.
Publicado: (2021)